CoChat

A Guide to Benzodiazepine Selection. Part II: Clinical Aspects

Teboul, Eric, Chouinard, Guy · 1991 · The Canadian Journal of Psychiatry

The DOI matches its Crossref record; 147 of the 148 references it cites were found in a registry or an index.

Abstract

To suit the specific needs of various clinical situations, selection of an appropriate benzodiazepine derivative should be based on consideration of their different pharmacokinetic and pharmacodynamic properties. Benzodiazepine derivatives that are rapidly eliminated produce the most pronounced rebound and withdrawal syndromes. Benzodiazepines that are slowly absorbed and slowly eliminated are most appropriate for the anxious patient, since these derivatives produce a gradual and sustained anxiolytic effect. Rapidly absorbed and slowly eliminated benzodiazepines are usually more appropriate for patients with sleep disturbances, since the rapid absorption induces sleep and the slower elimination rate may induce less tolerance to the sedative effect. Rational selection of a benzodiazepine for the elderly and for the suspected drug abuser is more problematic. The relevant pharmacokinetic and clinical considerations for these users are discussed. Certain derivatives may possess pharmacodynamic properties not shared by the entire benzodiazepine class; empirical studies have suggested the existence of antipanic properties for alprazolam and clonazepam, antidepressant properties for alprazolam, and anti-manic properties for clonazepam and possibly lorazepam.

Overview

Integrity signals

Registry

Crossref · 10.1177/070674379103600117

Cites

147 of 147 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 147 references

Research works printed but not linked: 46

  1. Vogel G.W., 1976, J Clin Pharmacol, 47, 81
  2. Dement W.C., 1978, Behav Med, 5, 25
  3. Kales A., 1978, Behav Med, 5, 25
  4. Chouinard G., 1986, J Clin Psychiatry Monograph Series, 4, 12
  5. Noyes R., 1988, J Clin Psychiatry, 49, 382
  6. Chouinard G., 1988, Can Med Assoc J, 139, 119
  7. Fontaine R., 1987, Efficacy and rebound anxiety of zopiclone and triazolam.
  8. Herman J.B., 1987, J Clin Psychiatry, 48, 22
  9. Petersson H., 1984, Dependence on tranquilizers.
  10. Rickels K., 1986, Psychopharmacol Bull, 22, 407
  11. 10.1001/jama.1977.03270280038018 · doi:10.1001/jama.1977.03270280038018 · Paper page
  12. Busto U., 1986, Acta Pharmacol Toxicol (Copenh), 203
  13. Ongini E., 1985, Clin Neuropharmacol, 8, 517
  14. Healey M., 1983, J Clin Psychiatry, 44, 436
  15. Mac D.S., 1985, J Clin Psychiatry, 46, 137
  16. Spinweber C.L., 1985, Sleep Res, 14, 60
  17. Scharf M.B., 1984, J Clin Psychiatry, 45, 51
  18. Scharf M.B., 1983, J Clin Psychiatry, 44, 362
  19. Scharf M.B., 1985, J Clin Psychiatry, 46, 518
  20. 10.1001/jama.1987.03400070083040 · doi:10.1001/jama.1987.03400070083040
  21. Annitto W.J., 1989, Am J Psychiatry, 145, 683
  22. Ciraulo D.A., 1989, Am J Psychiatry, 145, 684
  23. Kryspin-Exner K., 1975, Int J Clin Pharmacol, 12, 13
  24. Ciraulo D.A., 1988, J Clin Psychiatry, 49, 333
  25. Sheehan D.V., 1982, Drug Ther Hosp, 7, 74
  26. Beaudry P., 1986, J Clin Psychiatry, 47, 83
  27. Tesar G.E., 1987, J Clin Psychiatry, 48, 16S
  28. Annable L., 1989, VIII World Congress of Psychiatry, Book of Abstracts, 422, 116
  29. Cassano G.B., 1973, The benzodiazepines.
  30. Fabre L.F., 1976, Curr Ther Res, 19, 661
  31. Fabre L.F., 1980, Curr Ther Res, 27, 474
  32. Lenox R.H., 1984, Psychopharmacol Bull, 20, 79
  33. Overall J.E., 1987, J Clin Psychiatry, 48, 51
  34. Overall J.E., 1987, J Clin Psychiatry, 48, 15
  35. Sethy V.H., 1982, Res Commun Chem Pathol Pharmacol, 36, 329
  36. Dunner D., 1987, J Clin Psychiatry, 7, 170
  37. Falk W.E., 1986, Biological Therapies in Psychiatry, 9, 6
  38. Rapaport M., 1985, Am J Psychiatry, 141, 146
  39. Mayerhoff D., 1986, NY State J Med, 86, 320
  40. Goodman W.K., 1987, J Clin Psychiatry, 48, 117
  41. Dubin W.R., 1988, J Clin Psychiatry, 49, 5
  42. Chouinard G., 1983, Biol Psychiatry, 4, 451
  43. Chouinard G., 1989, Clonazepam in acute mania and manic spectrum diseases, 315
  44. Harms L., 1985, Pharmabulletin (Health Department of Victoria, Australia), 104, 117
  45. Freinhar J.P., 1985, J Clin Psychiatry, 46, 29
  46. Modell J.G., 1986, J Clin Psychopharmacol, 6, 385

Cited by

See all 25

Metadata

Authors
Teboul, E., & Chouinard, G.
Affiliations
  • McGill University (CA)
  • Institut universitaire en santé mentale de Montréal (CA)
Venue
The Canadian Journal of Psychiatry
Published
1991-02
Volume
36
Issue
1
Pages
62-73
ISSN
  • 0706-7437 (ISSN-L)
  • 1497-0015
OpenAlex
W142572826
Cited by
25
References
148
Citations by year
2026: 1 · 2023: 1 · 2021: 1 · 2020: 1 · 2015: 1 · 2013: 1
FWCI
0.82
Type
journal article
Language
en
Open access
closed
Licence
journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
Locations
  • The Canadian Journal of Psychiatry (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
  • Physical Sciences › Chemistry › Organic Chemistry › Synthesis and pharmacology of benzodiazepine derivatives
  • Health Sciences › Medicine › Anesthesiology and Pain Medicine › Anesthesia and Sedative Agents
Keywords
benzodiazepines, pharmacokinetics, pharmacodynamics, anxiolytic effects, sleep disorders, elderly patients, drug abusers, alprazolam, clonazepam, lorazepam, antidepressant effects
MeSH terms
Aged, Anxiety Disorders, Benzodiazepines, Depressive Disorder, Dose-Response Relationship, Drug, Humans, Panic, Psychomotor Agitation, Anti-Anxiety Agents

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A Guide to Benzodiazepine Selection. Part II: Clinical Aspects. https://app.cochat.ai/papers/10.1177/070674379103600117
The paper
Teboul, E., & Chouinard, G. (1991). A Guide to Benzodiazepine Selection. Part II: Clinical Aspects. The Canadian Journal of Psychiatry. https://doi.org/10.1177/070674379103600117

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.